142 related articles for article (PubMed ID: 26355760)
1. Pharmacogenetic-guided Warfarin Dosing Algorithm in African-Americans.
Alzubiedi S; Saleh MI
J Cardiovasc Pharmacol; 2016 Jan; 67(1):86-92. PubMed ID: 26355760
[TBL] [Abstract][Full Text] [Related]
2. Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.
Drozda K; Wong S; Patel SR; Bress AP; Nutescu EA; Kittles RA; Cavallari LH
Pharmacogenet Genomics; 2015 Feb; 25(2):73-81. PubMed ID: 25461246
[TBL] [Abstract][Full Text] [Related]
3. Race influences warfarin dose changes associated with genetic factors.
Limdi NA; Brown TM; Yan Q; Thigpen JL; Shendre A; Liu N; Hill CE; Arnett DK; Beasley TM
Blood; 2015 Jul; 126(4):539-45. PubMed ID: 26024874
[TBL] [Abstract][Full Text] [Related]
4. CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.
Scott SA; Jaremko M; Lubitz SA; Kornreich R; Halperin JL; Desnick RJ
Pharmacogenomics; 2009 Aug; 10(8):1243-55. PubMed ID: 19663669
[TBL] [Abstract][Full Text] [Related]
5. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.
Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS
Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801
[TBL] [Abstract][Full Text] [Related]
6. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.
Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O
Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms.
Nagai R; Ohara M; Cavallari LH; Drozda K; Patel SR; Nutescu EA; Perera MA; Hernandez W; Kaneko N; Hibiya M; Takahashi H
Pharmacogenomics; 2015; 16(3):217-25. PubMed ID: 25712185
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.
Perera MA; Cavallari LH; Limdi NA; Gamazon ER; Konkashbaev A; Daneshjou R; Pluzhnikov A; Crawford DC; Wang J; Liu N; Tatonetti N; Bourgeois S; Takahashi H; Bradford Y; Burkley BM; Desnick RJ; Halperin JL; Khalifa SI; Langaee TY; Lubitz SA; Nutescu EA; Oetjens M; Shahin MH; Patel SR; Sagreiya H; Tector M; Weck KE; Rieder MJ; Scott SA; Wu AH; Burmester JK; Wadelius M; Deloukas P; Wagner MJ; Mushiroda T; Kubo M; Roden DM; Cox NJ; Altman RB; Klein TE; Nakamura Y; Johnson JA
Lancet; 2013 Aug; 382(9894):790-6. PubMed ID: 23755828
[TBL] [Abstract][Full Text] [Related]
9. Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients.
Cho SM; Lee KY; Choi JR; Lee KA
Yonsei Med J; 2016 May; 57(3):635-40. PubMed ID: 26996562
[TBL] [Abstract][Full Text] [Related]
10. Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy.
Limdi NA; Wiener H; Goldstein JA; Acton RT; Beasley TM
Blood Cells Mol Dis; 2009; 43(1):119-28. PubMed ID: 19297219
[TBL] [Abstract][Full Text] [Related]
11. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.
Cho HJ; On YK; Bang OY; Kim JW; Huh W; Ko JW; Kim JS; Lee SY
Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797
[TBL] [Abstract][Full Text] [Related]
12. Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai population.
Chumnumwat S; Yi K; Lucksiri A; Nosoongnoen W; Chindavijak B; Chulavatnatol S; Sarapakdi A; Nathisuwan S
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29243335
[TBL] [Abstract][Full Text] [Related]
13. Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.
Pathare A; Al Khabori M; Alkindi S; Al Zadjali S; Misquith R; Khan H; Lapoumeroulie C; Paldi A; Krishnamoorthy R
J Hum Genet; 2012 Oct; 57(10):665-9. PubMed ID: 22854539
[TBL] [Abstract][Full Text] [Related]
14. Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms.
Kubo K; Ohara M; Tachikawa M; Cavallari LH; Lee MTM; Wen MS; Scordo MG; Nutescu EA; Perera MA; Miyajima A; Kaneko N; Pengo V; Padrini R; Chen YT; Takahashi H
Pharmacogenomics J; 2017 Dec; 17(6):494-500. PubMed ID: 27503578
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Novel Warfarin Dosing Algorithm for Korean Patients With
Cho EH; Lee K; Yang M; Choi R; Baek SY; Sohn I; Kim JS; On YK; Bang OY; Cho HJ; Lee SY
Ann Lab Med; 2020 May; 40(3):216-223. PubMed ID: 31858761
[TBL] [Abstract][Full Text] [Related]
16. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
Schwartz JB; Kane L; Moore K; Wu AH
J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
[TBL] [Abstract][Full Text] [Related]
17. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.
Wu AH; Wang P; Smith A; Haller C; Drake K; Linder M; Valdes R
Pharmacogenomics; 2008 Feb; 9(2):169-78. PubMed ID: 18370846
[TBL] [Abstract][Full Text] [Related]
18. Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record.
Ramirez AH; Shi Y; Schildcrout JS; Delaney JT; Xu H; Oetjens MT; Zuvich RL; Basford MA; Bowton E; Jiang M; Speltz P; Zink R; Cowan J; Pulley JM; Ritchie MD; Masys DR; Roden DM; Crawford DC; Denny JC
Pharmacogenomics; 2012 Mar; 13(4):407-18. PubMed ID: 22329724
[TBL] [Abstract][Full Text] [Related]
19. Dosage individualization of warfarin using artificial neural networks.
Saleh MI; Alzubiedi S
Mol Diagn Ther; 2014 Jun; 18(3):371-9. PubMed ID: 24574079
[TBL] [Abstract][Full Text] [Related]
20. Genetic and clinical predictors of warfarin dose requirements in African Americans.
Cavallari LH; Langaee TY; Momary KM; Shapiro NL; Nutescu EA; Coty WA; Viana MA; Patel SR; Johnson JA
Clin Pharmacol Ther; 2010 Apr; 87(4):459-64. PubMed ID: 20072124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
